Participate in Research

Browse Clinical Trials
MIND Study for Adults ages 55+ with Memory Concerns
Protocol: STUDY00004064
Full Title
Alzheimer's Therapeutic Research Institute Memory Improvement through Nicotine Dosing or Long-Term Nicotine Treatment of Mild Cognitive Impairment
Description
This study enrolls adults ages 55-90 who have concerns about memory. The purpose of the Memory Improvement Through Nicotine Dosing (MIND) study is to learn whether Nicotine absorbed through the skin through a daily nicotine patch improves attention, learning, and memory in folks with mild cognitive impairment.

You will attend up to 12 visits with the study team over about 2 years. You will wear a skin patch, containing either nicotine or placebo, for about 16 hours per day while participating. A placebo looks like the study drug but has no active ingredients. Neither you or the study team will know which group you are in. Study visits take place at UBMD Neurology outpatient locations in Western New York.
Compensation: No
Eligibility
Adults ages 55-90.
Must be a non-smoker.
Must have a memory concern as reported by participant, study partner, or clinician.
Study Partner is available who has frequent contact with the participant (e.g. an average of 10 hours per week or more), and can accompany the participant to most visits to answer questions about the participant.
Age Group: Adults
Principal Investigator: KINGA SZIGETI
ClinicalTrials.gov: Open Study
Contact(s)
KINGA SZIGETI
szigeti@buffalo.edu
+1 716-888-4722
Nicholas Audino
ncaudino@buffalo.edu

Want to Learn More?

Let us know how the study team can reach you. If you do not hear back within 2 business days, then reach out to the study team directly at the contact information above and someone will assist you.

Your information will be shared only with the research study team and administrative staff for recruitment and will remain confidential. Your information will be stored until study recruitment is closed. Should you no longer want this information to be provided in the aforementioned ways, please contact the study team directly.

Study teams can login to review submissions
Study Team Login